全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
药学学报  2015 

基于酶敏感机制的可激活细胞穿透肽在靶向输送系统中的应用

, PP. 141-147

Keywords: 细胞穿透肽,可激活细胞穿透肽,酶敏感

Full-Text   Cite this paper   Add to My Lib

Abstract:

细胞穿透肽的细胞膜穿透作用借助于一种非选择性和受体非依赖性的方式。该特点使得细胞穿透肽介导的细胞摄取过程适用于较广泛的细胞类型,而这种普遍性对于癌症治疗和诊断领域的应用无疑是重大障碍。因此,将体循环给药的细胞穿透肽惰化形式在肿瘤等病变区域选择性地转变为活化态成为研究热点。本文重点关注引入酶敏感机制的可激活细胞穿膜肽及其靶向递送系统,对此类传递载体的研究概况进行综述。

References

[1]  reny,hauerts,lojh,etal.identificationandcharacterizationofreceptor-specificpeptidesforsirnadelivery[j].acsnano,2012,6:8620-8631.
[2]  feilk,renl,zarojl,etal.theinfluenceofnetchargeandchargedistributiononcellularuptakeandcytosoliclocalizationofarginine-richpeptides[j].jdrugtarget,2011,19:675-680.
[3]  chengzl,zakiaa,huijz,etal.multifunctionalnanoparticles:costversusbenefitofaddingtargetingandimagingcapabilities[j].science,2012,338:903-910.
[4]  jiangt,olsones,nguyenqt,etal.tumorimagingbymeansofproteolyticactivationofcell-penetratingpeptides[j].procnatlacadsciusa,2004,101:17867-17872.
[5]  zhangxk,zhangx,wangfs.intracellulartransductionandpotentialoftatptdanditsanalogs:frombasicdrugdeliverymechanismtoapplication[j].expertopindrugdeliv,2012,9:457-472.
[6]  macewansr,chilkotia.harnessingthepowerofcell-penetratingpeptides:activatablecarriersfortargetingsys-temicdeliveryofcancertherapeuticsandimagingagents[j].wileyinterdisciprevnanomednanobiotechnol,2013,5:31-48.
[7]  olsones,aguilerata,jiangt,etal.invivocharacteriza-tionofactivatablecellpenetratingpeptidesfortargetingproteaseactivityincancer[j].integrbiol,2009,1:382-393.
[8]  aguilerata,olsones,timmersmm,etal.systemicinvivodistributionofactivatablecellpenetratingpeptidesissuperiortothatofcellpenetratingpeptides[j].integrbiol,2009,1:371-381.
[9]  olsones,jiangt,aguilerata,etal.activatablecellpenetratingpeptideslinkedtonanoparticlesasdualprobesforinvivofluorescenceandmrimagingofproteases[j].procnatlacadsciusa,2010,107:4311-4316.
[10]  nguyenqt,olsones,aguilerata,etal.surgerywithmolecularfluorescenceimagingusingactivatablecell-penetratingpeptidesdecreasesresidualcancerandimprovessurvival[j].procnatlacadsciusa,2010,107:4317-4322.
[11]  watkinsga,jonesef,scottshellm,etal.developmentofanoptimizedactivatablemmp-14targetedspectimagingprobe[j].bioorgmedchem,2009,17:653-659.
[12]  vanduijnhovensmj,robillardms,nicolayk,etal.tumortargetingofmmp-2/9activatablecell-penetratingimagingprobesiscausedbytumor-independentactivation[j].jnuclmed,2011,52:279-286.
[13]  wangpc,qixr.thedesignandenzymatichydrolysisofactivatablecell-penetratingpeptide[j].actapharmsin(药学学报),2010,45:1048-1051.
[14]  shinq,gaow,xiangb,etal.enhancingcellularuptakeofactivatablecell-penetratingpeptide-doxorubicinconjugatebyenzymaticcleavage[j].intjnanomed,2012,7:1613-1621.
[15]  xiahm,gugz,huqy,etal.activatablecellpenetratingpeptide-conjugatednanoparticleswithenhancedpermeabilityforsite-specifictargetingdeliveryofanticancerdrug[j].bioconjugchem,2013,24:419-430.
[16]  gaow,xiangb,mengtt,etal.chemotherapeuticdrugdeliverytocancercellsusingacombinationoffolatetargetingandtumormicroenvironment-sensitivepolypeptides[j].biomaterials,2013,34:4137-4149.
[17]  huangsx,shaok,liuy,etal.tumor-targetingandmicroenvironment-responsivesmartnanoparticlesforcombinationtherapyofantiangiogenesisandapoptosis[j].acsnano,2013,7:2860-2871.
[18]  olsones,whitneyma,friedmanb,etal.invivofluorescenceimagingofatheroscleroticplaqueswithactivatablecell-penetratingpeptidestargetingthrombinactivity[j].integrbiol,2012,4:595-605.
[19]  chenb,friedmanb,whitneyma,etal.thrombinactiv-ityassociatedwithneuronaldamageduringacutefocalischemia[j].jneurosci,2012,32:7622-7631.
[20]  whitneym,savariaren,friedmanb,etal.ratiometricactivatablecell-penetratingpeptidesproviderapidinvivoreadoutofthrombinactivation[j].angewchemintedengl,2012,52:325-330.
[21]  gallwitzm,enokssonm,thorpem,etal.theextendedcleavagespecificityofhumanthrombin[j].plosone,2012,7:e31756.
[22]  vanberkelss,vanderleeb,vandelftfl,etal.fluoro-genicpeptide-basedsubstratesformonitoringthrombinactivity[j].chemmedchem,2012,7:606-617.
[23]  williamssa,merchantrf,garrett-mayere,etal.aprostate-specificantigen-activatedchannel-formingtoxinastherapyforprostaticdisease[j].jnatlcancerinst,2007,99:376-385.
[24]  clarkmr,aliyaha,leecw,etal.enzymatictriggeredreleaseofanhiv-1entryinhibitorfromprostatespecificantigendegradablemicroparticles[j].intjpharm,2011,413:10-18.
[25]  perners,hofermd,kimr,etal.prostate-specificmembraneantigenexpressionasapredictorofprostatecancerprogression[j].humpathol,2007,38:696-701.
[26]  xiangb,dongdw,shinq,etal.psa-responsiveandpsma-mediatedmultifunctionalliposomesfortargetedtherapyofprostatecancer[j].biomaterials,2013,34:6976-6991.
[27]  zhul,katep,torchilinvp.matrixmetalloprotease2-responsivemultifunctionalliposomalnanocarrierforenhancedtumortargeting[j].acsnano,2012,6:3491-3498.
[28]  madx,shinq,qixr.distincttransductionmodesofarginine-richcell-penetratingpeptidesforcargodeliveryintotumorcells[j].intjpharm,2011,419:200-208.
[29]  levij,kothapallisr,matj,etal.design,synthesis,andimagingofanactivatablephotoacousticprobe[j].jamchemsoc,2010,132:11264-11269.
[30]  savariaren,felsencn,nashin,etal.real-timeinvivomoleculardetectionofprimarytumorsandmetastaseswithratiometricactivatablecell-penetratingpeptides[j].cancerres,2013,73:855-864.
[31]  huangs,shaok,kuangyy,etal.tumortargetingandmicroenvironment-responsivenanoparticlesforgenedelivery[j].biomaterials,2013,34:5294-5302.
[32]  changpv,dubedh,slettenem,etal.astrategyfortheselectiveimagingofglycansusingcagedmetabolicprecursors[j].jamchemsoc,2010,132:9516-9518.
[33]  gounea,shinder,dehnertkw,etal.intracellularcargodeliverybyanoctaargininetransporteradaptedtotargetprostatecancercellsthroughcellsurfaceproteaseactivation[j].bioconjugchem,2006,17:787-796.
[34]  yaov,berkmance,choijk,etal.expressionofpros-tate-specificmembraneantigen(psma),increasescellfolateuptakeandproliferationandsuggestsanovelroleforpsmaintheuptakeofthenon-polyglutamatedfolate,folicacid[j].prostate,2010,70:305-316.
[35]  whitneym,crispjl,olsones,etal.parallelinvivoandinvitroselectionusingphagedisplayidentifiesprotease-dependenttumor-targetingpeptides[j].jbiolchem,2010,285:22532-22541.
[36]  fuh,hugl,heq.preparationofcellpenetratingpep-tidetatandcleavablepegco-modifiedliposomesloadedwithpaclitaxelanditsinvitroapoptosisassay[j].actapharmsin(药学学报),2014,49:1054-1061.
[37]  harristj,vonmaltzahng,lordme,etal.protease-triggeredunveilingofbioactivenanoparticles[j].small,2008,4:1307-1312.
[38]  mokh,baekh,ahnch,etal.pegylatedandmmp-2specificallydepegylatedquantumdots:comparativeevaluationofcellularuptake[j].langmuir,2009,25:1645-1650.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133